| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1M | — | +2.9% |
| Cost of Revenue | $3.2M | — | -0.3% |
| Gross Profit | $6.9M | — | +4.4% |
| R&D Expense | $1.6M | — | -9.3% |
| SG&A Expense | $3.6M | — | -8.2% |
| Operating Income | -$3.2M | — | +10.3% |
| Pre-tax Income | -$2.8M | — | +15.2% |
| Income Tax | $187K | — | +36.5% |
| Net Income | -$3.0M | — | +13.2% |
| EPS (Basic) | -$0.07 | — | +12.5% |
| EPS (Diluted) | -$0.07 | — | +12.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.4M | -19.4% | -42.4% |
| Short-term Investments | $4.3M | +0.9% | +148.5% |
| Accounts Receivable | $4.8M | +17.8% | +3.5% |
| Inventory | $3.5M | +13.6% | +5.3% |
| Current Assets | $25.7M | -6.9% | -17.5% |
| Total Assets | $36.8M | -4.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | +17.9% |
| Capital Expenditures | $328K | — | -51.1% |
| Investing Cash Flow | -$494K | — | +73.9% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | -$2.5M | — | +24.6% |
| -10.1% |
| Current Liabilities | $9.4M | +12.5% | -19.6% |
| Long-term Debt | $10.9M | -2.6% | — |
| Total Liabilities | $27.8M | +1.9% | +44.7% |
| Stockholders' Equity | $9.0M | -21.1% | -58.5% |